These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32212822)

  • 21. The ethical, legal and social context of harm reduction.
    Pauly B; Goldstone I; McCall J; Gold F; Payne S
    Can Nurse; 2007 Oct; 103(8):19-23. PubMed ID: 17990401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding the crisis in harm reduction funding in Central and Eastern Europe.
    Miovský M; Miklíková S; Mravčík V; Grund JP; Černíková T
    Harm Reduct J; 2020 Oct; 17(1):83. PubMed ID: 33092597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug policy and harm reduction in the Middle East and North Africa: The role of civil society.
    Aaraj E; Jreij Abou Chrouch M
    Int J Drug Policy; 2016 May; 31():168-71. PubMed ID: 27140430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The politics of harm reduction in federal prisons.
    Watson TM
    Int J Drug Policy; 2014 Sep; 25(5):916-23. PubMed ID: 25018152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pricing of alcohol in Canada: A comparison of provincial policies and harm-reduction opportunities.
    Giesbrecht N; Wettlaufer A; Thomas G; Stockwell T; Thompson K; April N; Asbridge M; Cukier S; Mann R; McAllister J; Murie A; Pauley C; Plamondon L; Vallance K
    Drug Alcohol Rev; 2016 May; 35(3):289-97. PubMed ID: 26530717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virtue ethics as an alternative to deontological and consequential reasoning in the harm reduction debate.
    Christie T; Groarke L; Sweet W
    Int J Drug Policy; 2008 Feb; 19(1):52-8. PubMed ID: 18226518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substance Use Education in Canadian Nursing Programs: A Student Survey.
    Gagnon M; Payne A; Denis-Lalonde D; Wilbur K; Pauly B
    J Nurs Educ; 2020 Sep; 59(9):510-513. PubMed ID: 32865584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peer engagement in harm reduction strategies and services: a critical case study and evaluation framework from British Columbia, Canada.
    Greer AM; Luchenski SA; Amlani AA; Lacroix K; Burmeister C; Buxton JA
    BMC Public Health; 2016 May; 16():452. PubMed ID: 27229314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of a participatory needs assessment demonstrate an opportunity to involve people who use alcohol in drug user activism and harm reduction.
    Crabtree A; Latham N; Bird L; Buxton J
    Harm Reduct J; 2016 Dec; 13(1):37. PubMed ID: 27938376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developing integrated community-based HIV prevention, harm reduction, and sexual and reproductive health services for women who inject drugs.
    Ayon S; Jeneby F; Hamid F; Badhrus A; Abdulrahman T; Mburu G
    Reprod Health; 2019 May; 16(Suppl 1):59. PubMed ID: 31138238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Supervised inhalation is an important part of supervised consumption services.
    Bourque S; Pijl EM; Mason E; Manning J; Motz T
    Can J Public Health; 2019 Apr; 110(2):210-215. PubMed ID: 30725386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toward a human-centered use of technology: a stakeholder analysis of harm reduction and CBO staff.
    Aronson ID; Bennett AS; Freeman R
    Harm Reduct J; 2020 Oct; 17(1):77. PubMed ID: 33076911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Policy Advocacy and Nursing Organizations: A Scoping Review.
    Chiu P; Cummings GG; Thorne S; Schick-Makaroff K
    Policy Polit Nurs Pract; 2021 Nov; 22(4):271-291. PubMed ID: 34787526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A harm reduction paradox: comparing China's policies on needle and syringe exchange and methadone maintenance.
    Smith K; Bartlett N; Wang N
    Int J Drug Policy; 2012 Jul; 23(4):327-32. PubMed ID: 22377341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contested space in the pharmacy: public attitudes to pharmacy harm reduction services in the West of Scotland.
    Gidman W; Coomber R
    Res Social Adm Pharm; 2014; 10(3):576-87. PubMed ID: 24021859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Harm reduction in practice - The Community Oriented Substance Use Programme in Tshwane.
    Scheibe A; Shelly S; Hugo J; Mohale M; Lalla S; Renkin W; Gloeck N; Khambule S; Kroukamp L; Bhoora U; Marcus TS
    Afr J Prim Health Care Fam Med; 2020 May; 12(1):e1-e6. PubMed ID: 32501031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peering into the literature: A systematic review of the roles of people who inject drugs in harm reduction initiatives.
    Marshall Z; Dechman MK; Minichiello A; Alcock L; Harris GE
    Drug Alcohol Depend; 2015 Jun; 151():1-14. PubMed ID: 25891234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treating Addictions: Harm Reduction in Clinical Care and Prevention.
    Drucker E; Anderson K; Haemmig R; Heimer R; Small D; Walley A; Wood E; van Beek I
    J Bioeth Inq; 2016 Jun; 13(2):239-49. PubMed ID: 27112489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Challenges and opportunities to integrating family members of injection drug users into harm reduction efforts within the Atlantic Canadian context.
    Jackson LA; Dykeman M; Gahagan J; Karabanow J; Parker J
    Int J Drug Policy; 2011 Sep; 22(5):385-92. PubMed ID: 21742479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stigmatizing harm reduction through language: a case study into the use of "addict" and opposition to supervised injection sites in Canada.
    Cortina SC
    J Addict Nurs; 2013; 24(2):102-7. PubMed ID: 24621488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.